SAN DIEGO, Calif., and GUANGZHOU, China, Wednesday, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnology (DaRui) announced today that the MassARRAY System has

The panel accurately and sensitively detects over 1600 variants of clinical significance AUSTIN, Texas — Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to

Carlsbad, CA, 07/11/18– Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving molecular diagnostic and biopharmaceutical companies, today announced it has reached a

First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business Salt Lake City, UT, USA and

Seattle, WA, April 16, 2018 – RareCyte, Inc., a global rare cell detection and liquid biopsy company announces its newest product, CyteFinder HT in conjunction

SAN DIEGO, Calif., and NANJING, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today

Salt Lake City, Utah, USA… Carterra Inc., an innovative label-free biosensor company, announced today that it has sold multiple units of its new, fully integrated,

Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization   Salt Lake City, Utah, USA…Carterra Inc., an innovative label-free biosensor

AUSTIN, Texas– Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology by bringing complex molecular tests

October 24, 2017 Ann Arbor, MI: Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC) announced today the completion of a Series A funding round

San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based

TrakCel Solution will electronically link Iovance with clinical sites, contract manufacturing organizations and couriers to schedule and track TIL therapies for each patient SAN CARLOS,